David Corey grew up in Cambridge, Massachusetts. He received his B.A. degree in chemistry from Harvard University and his Ph.D. degree in chemistry from the University of California Berkeley, working under the supervision of Dr. Peter Schultz to develop sequence specific engineering nucleases.
He did postdoctoral work in the laboratory of Dr. Charles Craik at the University of California, San Francisco, where he studied protein engineering and protease function.
Dr. Corey joined the UT Southwestern Pharmacology Department in 1992. He was promoted to Associate Professor with tenure in 1998 and Full Professor in 2003. In 2014, he was named the Rusty Kelley Professor of Medical Sciences. He is also a member of the Department of Biochemistry and the Simmons Cancer Center.
Dr. Corey is an Executive Editor for Nucleic Acids Research and is on the Editorial Board of Cancer Research, Molecular Therapy Nucleic Acids, and Oligonucleotide Therapeutics. He is the author of more than 147 papers and has received funding from the Welch Foundation, NIH, the McKnight Award for Neuroscience Research, the American Heart Association, the Cure Huntington Disease Initiative, and the Freidreich's Ataxia Association.